Colloid infusions are often given to treat hypotension in preterm infants. The aim of this work was to assess whether it was the amount of protein or the volume of the colloid infused which accounted for the observed increase in blood pressure. Sixty preterm infants were randomised (20 in each group) to receive 5 ml/kg 20% albumin, 15 ml/kg fresh frozen plasma, or 15 mI/kg 4 5% albumin. All infusions were given at a rate of 5 ml/kg/hour in addition to maintenance fluids. The infants were randomised when hypotensive (systolic blood pressure less than 40 mm Hg for two hours). There was no significant difference in the blood pressure of the three groups before or one hour after beginning the infusion. The mean increase in blood pressure one hour after completing the infusion, however, was significantly lower in infants receiving 20% albumin: 9% compared with 17% in the group receiving 4-5% albumin, and 19% in the group receiving fresh frozen plasma. It is concluded that the volume infused rather than albumin load is important in producing a sustained increase in blood pressure. (Arch Dis Child 1992,67:1185 Colloid infusions are often used to treat hypotension in sick preterm infants. This hypotension may result from hypovolaemia due to fluid losses via the kidney and skin and increased leakage from capillaries in the lungs, or from myocardial depression due to asphyxia or hypoxia and resulting poor cardiac output. In the latter instance it seems preferable to avoid a large fluid load, but there are no data available to assess whether the improvement in blood pressure is the result of the protein or of the volume load infused. The aim of this study, therefore, was to compare the effects of colloid infusions of different volumes and protein content on blood pressure levels in hypotensive preterm infants and thus to determine the most efficacious type of colloid infusion.
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Subjects and methods
Consecutive preterm infants were entered into the randomised trial when hypotensive but not overloaded with fluid. Hypotension was defined as a systolic blood pressure less than 40 mm Hg for two successive hours. None of the infants had clinical evidence of fluid overload. They were randomised by drawing a sealed envelope which instructed that they should receive one of three treatments: 5 ml/kg 20% albumin (200 g/l albumin-that is, 1 g/kg of albumin), or 15 ml/kg fresh frozen plasma (total protein 80 g/l, albumin 50 g/lthat is, 2 g/kg of protein or 0 75 g/kg of albumin), or 15 ml/kg 4 5% albumin (45 g/l albumin-that is, 0-675 g/kg of albumin). All infusions were given at a rate of 5 ml/kg/hour in addition to maintenance fluids. Thus the 20% albumin infusion was completed in one hour, but the other two infusions only after three hours. Systolic blood pressure was measured one hour after beginning the infusion and one hour after completing the infusion, and also four hours after beginning the infusions (that is, one hour after completing fresh frozen plasma and 4 5% albumin infusion, but three hours after completing the 20% albumin infusion).
Systolic blood pressure was measured either from an indwelling arterial catheter sited for clinical purposes or using a non-invasive Doppler method. All blood pressure measurements were made with the infant in the supine position. Measurements were not made if the infants had been recently handled, were crying, or were feeding.
Arterial cannulation was attempted on all admissions to the neonatal intensive care unit if the infant's oxygen requirements were in excess of 40% for six hours or the infant had a birth weight of less than 1000 g and was dependent on a ventilator. The unit's routine policy was first to attempt cannulation of the umbilical artery with a 4 or 5 French gauge catheter and if this was unsuccessful a peripheral artery was cannulated with a 24 or 26 French gauge cannula. Once arterial access was gained, blood pressure monitoring was begun. The arterial line was connected to a transducer (Medex Accuflush) and thence to a continuous monitor (Horizon 2000 monitor, Mennen). This gives a continuous display of the arterial waveform and minute by minute changes in the diastolic and systolic blood pressure. The arterial waveform was considered damped if the dicrotic notch was absent' and if there was less than a 10 mm Hg difference between the systolic and diastolic blood pressure. Only the results of non-damped systolic blood pressure measurements were used for this study. Measurements were recorded over a 10 minute period and the mean of the results was calculated.
A Doppler technique was used for blood pressure measurement in those infants with-out an arterial line in situ. An appropriately sized2 cuff (Tricomed) was placed over the infant's upper arm. A coupling gel was applied over the brachial artery and the Doppler transducer (Ultrasonic Doppler flow detector) applied to this area. The operating frequencies of the transducer were from 8 to 9 7 MHz. The cuff was slowly inflated manually using a portable Accoson sphygmomanometer and then released until arterial pulsations were audible. The systolic pressure is the first signal heard. Three measurements were made on each occasion and the systolic blood pressure was expressed as the mean of these results. No infant required a change in blood pressure measurement technique during the study.
STATISTICAL ANALYSIS
The blood pressure immediately before beginning the colloid infusion was taken as the baseline blood pressure. The change in blood pressure from the baseline one hour after beginning, one hour after completing, and four hours after beginning the infusion was expressed as a percentage of the baseline blood pressure. Differences between the three groups were assessed for statistical significance using the Wilcoxon rank sum test. Using the results derived from 20 infants previously treated on our unit for hypotension with a colloid infusion we calculated that it would be necessary to randomise 60 infants (20 in each group) to detect with 80% power at the 5% level a significant difference of 10% in the change in blood pressure between the groups.
PATIENTS
Sixty patients were recruited into the study, 20 infants in each group. Table 1 shows that there was no significant difference in the gestational age, birth weight, length of ventilation, or postnatal age between the three groups.
Results
There was no significant difference in the blood pressure of the three groups at entry to the trial or after one hour of beginning or completing the colloid infusions. At four hours after beginning the infusion-that is, three hours after completing the 20% albumin infusion, the blood pressure of that group was significantly lower than that of the 4 5% albumin and the fresh frozen plasma groups (p<005, p<0 01, respectively) (table 2). The median increase in blood pressure one hour after beginning the colloid infusions tended to be greatest in those infants who had received 4*5% albumin. The increase in blood pressure one hour after completing the infusions was significantly greater in the infants who had received 4-5% albumin or fresh frozen plasma compared with those who had received 20% albumin (p<0 05). This difference in the increase in blood pressure was even more marked (p<0 01) when the three groups were compared at four hours after beginning the infusion (table 3, figure) . it consistently under records the systolic and diastolic blood pressures of hypotensive very low birthweight infants.7
Although our study population were all very young, in a proportion it was not possible to make invasive arterial measurements. This was predictable from our earlier trial, which found by day four that 20% of infants no longer had an arterial catheter in situ and of those who did, a further 20% had a damped waveform.4 There was, however, no significant difference in the number of infants in each group in whom blood pressure was measured using the Doppler technique. In addition, as our study period was of only four hours duration, we did not need to change our measurement technique in any infant, thus eliminating a further source of bias.
Infants were regarded as hypotensive if their systolic blood pressure was less than 40 mm Hg. This level was used as this is our routine clinical practice and has also been previously recommended.8 This level may be inappropriate for the most immature infants included in our study, but there is little normative data available for such infants on which to base a more accurate diagnosis of hypotension. As there was no significant difference in the median or range of gestational age between our three groups, our use of a single level of blood pressure on which to diagnose hypotension in unlikely to have biased our results. Other studies9 10 have used the mean rather than the systolic level, as it was felt to be more accurate than the systolic blood pressure which could be affected by damping. In this study we avoided this possible source of error by using only arterial measurements which were taken from an undamped arterial waveform. We felt it important to use systolic blood pressure levels as these can be measured in all infants regardless of the presence of an arterial line.
Albumin infusion has previously been associated with a reduction of tissue oedema, as evidenced by considerable weight loss.11
There is the theoretical concern that by increasing blood volume it might prolong the patency of the ductus arteriosus. 12 In only one study has its use been associated with pulmonary oedema'3 and this did not occur in three other studies. 1I 13 14 Several groups have reported that albumin infusion increases blood pressure. 13-15 The effects previously recorded, however, were small and transient. Compared with the present trial, a smaller amount of albumin and smaller volume of fluid was infused in all three studies.'3-'5
The present results suggest that the volume rather than just the total amount of protein given is more effective in producing a sustained increase in blood pressure. The larger volumes of fluid were given at the same rate and hence over a longer period of time. The prolonged infusion of protein may also have had a greater effect by producing a sustained increase in oncotic pressure. Administration by such a method may have resulted in less protein loss from the circulation,'6 as the increase in albumin concentration would be expected to be smaller,'5 thus resulting in a lower diffusion gradient. This hypothesis is supported by our finding of a significantly lower blood pressure in the 20% albumin group compared with the other two groups at the same time after beginning the infusion (table 2) .
There was no significant difference between the three groups in the blood pressure levels or change in blood pressure one hour after beginning the infusions. At that early stage all of the infants had received the same volume of fluid related to body weight (5 ml/kg/hour), but those receiving 20% albumin had been given a greater protein load. This further suggests that the volume of the fluid rather than protein load alone is responsible for the major effect on blood pressure.
We conclude that it is not only the amount of protein administered but also the volume of the vehicle infused that is important in producing a sustained increase in blood pressure in hypotensive preterm infants.
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